Paras Healthcare will open its Rs 1,450-crore initial public offering on October 21, aiming to raise funds for debt reduction and expansion. With the issue closing on October 23, investors will be closely watching the company’s ability to manage its debt levels and maintain its recent profit turnaround.
Paras Healthcare, a hospital chain with a presence across North India, Bihar, and Jharkhand, has announced the launch of its initial public offering (IPO) for October 21, 2026. The subscription window will remain open for three days, closing on October 23, with anchor investors gaining access on October 19. The company aims to raise Rs 1,450 crore through this issue, with shares expected to list on the stock exchanges by October 28.
IPO Structure and Financial Context
The public issue is composed of a fresh equity share sale of Rs 500 crore and an offer for sale (OFS) of Rs 950 crore. In an offer for sale, existing shareholders sell their stake, meaning the proceeds from that portion go to the selling investors, not the company. Major stakeholders participating in the OFS include founder Dr. Dharminder Kumar Nagar and affiliate entities of the private equity firm Creador.
A primary goal for the fresh capital is debt reduction. As of March 2026, the company reported consolidated debt of approximately Rs 854.10 crore. Management intends to use Rs 375 crore of the fresh funds to pay down this debt, which may help improve the company's interest burden. Financially, the company has shown a recovery, reporting a net profit of Rs 43.83 crore for the fiscal year ended March 2026, on revenue of Rs 1,628.78 crore, marking a turnaround from previous years of losses.
Operational Footprint and Expansion
Paras Healthcare currently operates eight hospitals under the 'Paras Health' brand, providing a total of 2,211 beds. The company is in the process of scaling its capacity to serve higher demand for specialized healthcare services, such as cardiac and neuro-sciences. New facilities are planned for Gurugram and Ludhiana, with the company targeting a total capacity of 3,011 beds by March 2028. The success of these expansion plans will depend on the company's ability to complete construction on time and maintain occupancy levels in both new and existing units.
Investor Risks and Monitorables
While the company is expanding, investors should be aware of several risk factors. The company faces concentration risk, as a significant portion of its revenue comes from a limited number of hospital locations and specific clinical specialties. Additionally, the company is subject to healthcare pricing regulations, which can impact profit margins. There are also pending civil and criminal legal cases involving the promoters and the entity itself. Future performance will depend on the company's ability to navigate these legal and regulatory hurdles while managing the execution risks associated with its large hospital construction projects. Investors may look for updates on debt reduction progress and the utilization rates of the new hospital capacity following the listing.